Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta
- PMID: 3746661
Differential induction of ethoxyresorufin-O-deethylase in tissues of the rat placenta
Abstract
The placenta of the rat during late gestation is comprised of the yolk sac membranes, labyrinth and basal zone, which are of fetal origin, and the decidua basalis, which is derived maternally. Studies investigated whether the placental monooxygenase activity induced by administration of beta-naphthoflavone (beta-NF) and 3-methylcholanthrene (3-MC) to pregnant rats was localized differentially in these separate portions of the organ. Ethoxyresorufin-O-deethylation (EROD) was measured by fluorometric assay in homogenates of the respective placental tissues and of intact fetuses. EROD was very low or undetectable in feto-placental homogenates from untreated control animals. The administration of beta-NF and 3-MC increased EROD activity 50-fold over control in labyrinth and fetal homogenates, 10- to 15-fold in decidua, 8- to 20-fold in fetal membranes and 8-fold in basal zone preparations. The apparent Km value for ethoxyresorufin was significantly lower than control for EROD in labyrinth preparations from both beta-NF- and 3-MC-treated animals. Enzyme activity in labyrinth homogenates was maximally induced by 3-MC treatment for 1 to 3 days. In contrast, EROD activity was maximal after 1 to 2 days beta-NF administration, but declined markedly with longer duration of treatments. Subsequent studies compared the in vitro effects of alpha-naphthoflavone (alpha-NF) and beta-NF on induced EROD in feto-placental homogenates. The two benzoflavones were found to be equipotent as inhibitors with IC50 values less than 1 microM for labyrinth, maternal liver and fetal preparations.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.Drug Metab Dispos. 1986 Jul-Aug;14(4):471-6. Drug Metab Dispos. 1986. PMID: 2873995
-
Effects of beta-naphthoflavone and 3-methylcholanthrene administered to pregnant rats on steroid metabolism in the isolated basal zone of the placenta.J Pharmacol Exp Ther. 1984 Sep;230(3):761-7. J Pharmacol Exp Ther. 1984. PMID: 6470979
-
Effects of beta-naphthoflavone on insulin receptor binding and protein kinase activity in rat liver and placenta.Mol Pharmacol. 1988 Mar;33(3):250-6. Mol Pharmacol. 1988. PMID: 2832720
-
Strain-dependent differences in the metabolism of 3-methylcholanthrene by maternal, placental, and fetal tissues of C57BL/6J and DBA/2J mice.Cancer Res. 1986 Nov;46(11):5671-5. Cancer Res. 1986. PMID: 3756914
-
Reduction in the transplacental carcinogenic effect of methylcholanthrene in mice by prior treatment with beta-naphthoflavone.Res Commun Chem Pathol Pharmacol. 1980 Dec;30(3):431-46. Res Commun Chem Pathol Pharmacol. 1980. PMID: 7255859
Cited by
-
The effects of β-naphthoflavone on rat placental development.J Toxicol Pathol. 2019 Oct;32(4):275-282. doi: 10.1293/tox.2019-0047. Epub 2019 Aug 20. J Toxicol Pathol. 2019. PMID: 31719754 Free PMC article.
-
Bioavailability and biotransformation of benzo(a)pyrene in an isolated perfused In situ catfish intestinal preparation.Environ Health Perspect. 1998 Mar;106(3):155-66. doi: 10.1289/ehp.98106155. Environ Health Perspect. 1998. PMID: 9449680 Free PMC article.